Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-Olanzapine 5Mg ODT Tab 30 By Jubilant Cadista Pharma Gen Zyprexa

Olanzapine 5Mg Tab 30 By Jubilant Cadista Pharma Gen Zyprexa Item No.:RX322091 NDC No.59746030632 59746-306-32 5974630632  UPC No.:359746306328 NDC No.59746-0306-32 UPC/GTIN No 359746-306328 359746306Olanzapine 5Mg Tab 30 By Jubilant Cadista Pharma Gen Zyprexa Item No.:RX322091 NDC No.59746030632 59746-306-32 5974630632  UPC No.:359746306328 NDC No.59746-0306-32 UPC/GTIN No 359746-306328 359746306Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.NDC 59746-0306-32 UPC/GTIN No.3-59746-30632-8 Mfg.Part No.30632BRAND: OLANZAPINE NDC: 59746-0306-32,59746030632 UPC: 3-59746-30632-8,359746306328

Rx Item-Olanzapine 5Mg ODT Tab 30 By Jubilant Cadista Pharma Gen Zyprexa

$428.22$9.99

Item No.:RX322091 NDC No.59746030632 59746-306-32 5974630632 UPC No.:359746306328 NDC No.59746-0306-32 UPC/GTIN No 359746-306328 359746306328 359746-306328 MPN 30632 Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,ResearchCo.,Uni.,VA,Vet & Wholesalers in scope of practice can order this RX Item. Rx Item No.Rx322091 Olanzapine 5mg Tab 30 by Jubilant Cadista Pharma Item No.3322091 NDC No.5974

Have a question?

Clinical Information
Gen. Code and Des.
45190 olanzapine ORAL TAB RAPDIS 5 MG
GCN and Des.
92007 olanzapine ORAL TAB RAPDIS 5 MG
Strength
5MG ODT
Dose Form
TABLET,DISINTEGRATING
Product Category
RX Pharmaceuticals
Fine Line Class
850085008510 All Rx Products
DEA Class
NC
OMP Family

AHFS Class
28160804 ATYPICAL ANTIPSYCHOTICS
28280000 ANTIMANIC AGENTS
Active Ingredients
6204 olanzapine 132539061
Inactive Ingredients
2272 mannitol 69658
2605 aspartame 22839470
3192 benzyl alcohol 100516



ZYPREXA - olanzapine tablet
ZYPREXA ZYDIS - olanzapine tablet, orally disintegrating
ZYPREXA INTRAMUSCULAR - olanzapine injection, powder, for solution
Eli Lilly and Company


WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS


Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. ZYPREXA (olanzapine) is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5.1, 5.13) and Patient Counseling Information


When using ZYPREXA and fluoxetine in combination, also refer to the Boxed Warning section of the package insert for Symbyax.


INDICATIONS AND USAGE


1.1 Schizophrenia
Oral ZYPREXA is indicated for the treatment of schizophrenia. Efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. In adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see Clinical Studies (14.1)].


When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see Warnings and Precautions (5.5)].


1.2 Bipolar I Disorder (Manic or Mixed Episodes)
Monotherapy - Oral ZYPREXA is indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. Efficacy was established in three clinical trials in adult patients with manic or mixed episodes of bipolar I disorder: two 3- to 4-week trials and one monotherapy maintenance trial. In adolescent patients with manic or mixed episodes associated with bipolar I disorder (ages 13-17), efficacy was established in one 3-week trial [see Clinical Studies (14.2)].


When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see Warnings and Precautions (5.5)].


Adjunctive Therapy to Lithium or Valproate - Oral ZYPREXA is indicated for the treatment of manic or mixed episodes associated with bipolar I disorder as an adjunct to lithium or valproate. Efficacy was established in two 6-week clinical trials in adults. The effectiveness of adjunctive therapy for longer-term use has not been systematically evaluated in controlled trials [see Clinical Studies (14.2)].

Olanzapine 5Mg Tab 30 By Jubilant Cadista Pharma Gen Zyprexa Item No.:RX322091 NDC No.59746030632 59746-306-32 5974630632  UPC No.:359746306328 NDC No.59746-0306-32 UPC/GTIN No 359746-306328 359746306
Olanzapine 5Mg Tab 30 By Jubil
Olanzapine 5Mg Tab 30 By Jubilant Cadista Pharma Gen Zyprexa Item No.:RX322091 NDC No.59746030632 59746-306-32 5974630632 UPC No.:359746306328 NDC No.59746-0306-32 UPC/GTIN No 359746-306328 359746306

Olanzapine 5Mg Tab 30 By Jubilant Cadista Pharma Gen Zyprexa Item No.:RX322091 NDC No.59746030632 59746-306-32 5974630632  UPC No.:359746306328 NDC No.59746-0306-32 UPC/GTIN No 359746-306328 359746306
Olanzapine 5Mg Tab 30 By Jubil
Olanzapine 5Mg Tab 30 By Jubilant Cadista Pharma Gen Zyprexa Item No.:RX322091 NDC No.59746030632 59746-306-32 5974630632 UPC No.:359746306328 NDC No.59746-0306-32 UPC/GTIN No 359746-306328 359746306

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
Click above for Zyprexa !
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

NDC 59746-0306-32 UPC/GTIN No.3-59746-30632-8 Mfg.Part No.30632
RX ITEM-Olanzapine 5Mg Tab 30 By Jubilan
NDC 59746-0306-32 UPC/GTIN No.3-59746-30632-8 Mfg.Part No.30632

BRAND: OLANZAPINE NDC: 59746-0306-32,59746030632 UPC: 3-59746-30632-8,359746306328
Olanzapine 5Mg Tab 30 By Jubilant Cadist
BRAND: OLANZAPINE NDC: 59746-0306-32,59746030632 UPC: 3-59746-30632-8,359746306328